2733. Evusheld (AZD7442) Uptake and COVID-19 Outcomes in Solid Organ Transplant Recipients: A Secondary Analysis

BACKGROUND: Evusheld is a pre-exposure prophylaxis for COVID-19. It was recommended for high-risk populations, including solid organ transplant (SOT) recipients, due to their increased risk of severe COVID-19 and suboptimal vaccine response. Evusheld received emergency use authorization (EUA) in 12/...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayek, Haya, Stopczynski, Tess, Khanfar, Asim, Qwaider, Yasmeen Z, Amarin, Justin Z, Stuhlreyer, Madge I, Alsabah, Samar, Frank, Samantha Economos, Johnson, Mackenzie, Perri, Roman, Schlendorf, Kelly, Birdwell, Kelly A, Dee, Kevin C, Dulek, Daniel, Spieker, Andrew J, Chappell, James, Halasa, Natasha B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678392/
http://dx.doi.org/10.1093/ofid/ofad500.2344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678392/
http://dx.doi.org/10.1093/ofid/ofad500.2344

Ejemplares similares